Results 81 to 90 of about 27,193 (247)

A Care Pathway for the Treatment of IBD Reduces Healthcare Costs and Is Cost‐Effective: Results of the Multicentre IBD Value Study

Alimentary Pharmacology &Therapeutics, EarlyView.
This study provides real‐world evidence that implementing an advanced therapy care pathway for patients with IBD leads to significant healthcare cost savings without compromising quality of life. These findings support broader implementation of care pathways in the management of patients with chronic conditions to optimise care delivery and resource ...
Elyke H. Visser, Martijn. A. Oude Voshaar, Reinier C. A. van Linschoten, Alexander G. L. Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K. Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C. Janneke van der Woude, R. L. West, D. van Noord   +12 more
wiley   +1 more source

Endometriosis presenting as a rectal stricture in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report [PDF]

Patients with ulcerative colitis (UC) are at an increased risk of colorectal cancer (CRC), which is compounded in the presence of other risk factors such as primary sclerosing cholangitis (PSC) and stricture.
Ibrahim Mian, Deloshaan Subhaharan, Subhaharan, D, Chorley, D, Pradeep Kakkadasam Ramaswamy, Mian, I, Kakkadasam Ramaswamy, P, Daniel Chorley   +7 more
core   +1 more source

Socioeconomic Inequalities in Receipt of Curative‐Intent Treatment and Survival After Surveillance‐Detected Hepatocellular Carcinoma: A Nationwide Cohort Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Socioeconomic inequalities in receipt of curative‐intent treatment and survival persist among individuals with surveillance‐detected HCC within a universal healthcare system. These findings suggest that surveillance alone is insufficient to ensure equitable outcomes and highlight the need for strategies addressing social determinants across the care ...
Hannes Hagström, Jeffrey V. Lazarus, Malin Sternby Eilard, Adam Bergman, Magnus Rizell, Per Sandström, Juan Vaz   +6 more
wiley   +1 more source

Pathogenesis of primary sclerosing cholangitis

, 2011
Primary sclerosing cholangitis (PSC) represents a chronic cholestatic liver disease with fibroobliterative sclerosis of intra- and/or extrahepatic bile ducts, eventually leading to biliary cirrhosis.The association with human leukocyte antigen (HLA) and ...
Fickert, Peter, Trauner, Michael, Peter Fickert, Michael Trauner, Marion J. Pollheimer, Halilbasic, Emina, Emina Halilbasic, Pollheimer, Marion J.   +7 more
core   +1 more source

Primary sclerosing cholangitis: diagnostic and management challenges

, 2017
Sanjeev Sirpal,1 Natasha Chandok2 1Department of Medicine, Centre Hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, QC, 2Department of Medicine, University of Western Ontario, London, ON, Canada ...
Sirpal S, Chandok N
core  

Primary Sclerosing Cholangitis: Diagnostic Criteria [PDF]

Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by inflammation and fibrosis of intra- and/or extrahepatic bile ducts leading to the formation of multifocal strictures alternated to bile duct dilatations. The diagnosis
Bonaiuto E., Sarcognato S., Motta R., Cazzagon N., Catanzaro E., Pezzato F., Peviani M.   +6 more
core   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction‐Associated Steatotic Liver Disease

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier, Ramon A. Hofmann, Michael Roden, Wolfgang Rathmann, Oliver Kuss   +4 more
wiley   +1 more source

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study

, 2003
AIM: IBD is a systemic disease associated with a large number of extraintestinal manifestations (EIMs). Our aim was to determine the prevalence of EIMs in a large IBD cohort in Veszprem Province in a 25-year follow-up study.
Dávid, Gyula, Balogh, Zsuzsanna, Tollas, Árpád, Lakatos, Péter László, Pandur, Tünde, Kuronya, Pál, Lakatos, László   +6 more
core  

Sclerosing cholangitis in the paediatric patient

, 2001
Sclerosing cholangitis in childhood is a heterogeneous condition, which has different aetiologies. Sclerosing cholangitis may be inherited and diagnosed in the neonatal period (neonatal sclerosing cholangitis); it may present later with features of ...
Vergani, D, Giorgina Mieli-Vergani, Diego Vergani, Mieli-Vergani, G   +3 more
core   +1 more source

‐related sclerosing cholangitis from primary sclerosing cholangitis

, 2022
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) and IgG4‐related sclerosing cholangitis (IgG4‐SC) are chronic fibro‐inflammatory immune‐mediated hepatobiliary conditions that are challenging to distinguish in a clinical setting.
Daniel C. Anthony, Michael Pavlides, Bolon, Jonathan, Orrell, Michael, Emmanuel A. Selvaraj, Probert, Fay, Bailey, Adam, Culver, Emma L., Fay Probert, Selvaraj, Emmanuel A., Rory Peters, Emma L. Culver, Anthony, Daniel C., Anthony, Daniel C, Michael Orrell, Radford‐Smith, Daniel E., Kate Lynch, Pavlides, Michael, Radford-Smith, Daniel E, Peters, Rory, Geremia, Alessandra, Culver, Emma L, Alessandra Geremia, Adam Bailey, Selvaraj, Emmanuel A, Jonathan Bolon, Lynch, Kate, Daniel E. Radford‐Smith   +27 more
core   +1 more source